about
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialVaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient dataTransdermal contraception.Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysisEffect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial.Efficacy and safety of a transdermal contraceptive system.Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.Conception rates in clomiphene citrate cycles with and without hormone supplementation: a pilot study.Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study GroupGastric dysrhythmias and nausea of pregnancy
P50
Q24622553-1482316B-6D91-456F-A4AF-8BF81AD205D9Q34143212-29BD8B39-8271-420F-8901-D51745C6096DQ34451393-83E569B9-5F06-4AB6-B6FE-28F25F1C4796Q34694463-FEA6351C-3F1F-4381-94F1-D7E8FF5470D0Q34694480-A10F1AB2-558F-4199-8AAE-C9726E72E665Q36487287-1C95BDC6-0D16-4EDD-8418-3AAAA6E10762Q43240651-00F07648-324E-4909-AB74-9C79AF86B41FQ43796300-4CEDB311-C1DE-44F9-80AC-807331426535Q43865733-2C26AF17-93AB-41FA-BE2E-50596FB2E3D9Q44505631-8687B104-DA80-4BBC-8AB9-EB6401633419Q44900686-514F89D2-3E3F-4364-A250-E950148A5E63Q46446600-0923F830-1AD7-429D-93E3-D1086B62C40AQ46590371-7B550BDB-9C47-4B6F-BB4F-53BC2D17BFBAQ61845605-701C0FDF-FB55-4356-9CC0-0E3ADB64A283Q68882994-91C81CB1-0678-47BD-9A7A-813E803810A3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
George W. Creasy
@ast
George W. Creasy
@en
George W. Creasy
@es
George W. Creasy
@nl
George W. Creasy
@sl
type
label
George W. Creasy
@ast
George W. Creasy
@en
George W. Creasy
@es
George W. Creasy
@nl
George W. Creasy
@sl
prefLabel
George W. Creasy
@ast
George W. Creasy
@en
George W. Creasy
@es
George W. Creasy
@nl
George W. Creasy
@sl
P106
P1153
7003615933
P21
P31
P496
0000-0002-6645-4238
P569
2000-01-01T00:00:00Z